MAQTOX is a global pharmaceutical development organization (PDO) redefining the path to innovation in drug discovery and development. We are more than just a Contract Research Organization (CRO) we are your dedicated partner in bringing transformative therapies to life. By seamlessly integrating laboratory and clinical services with expert regulatory guidance, Maqtox delivers innovative, efficient, and high-quality solutions tailored to the unique needs of each client.
Our purpose is simple but powerful: to accelerate the development of life-changing treatments and improve global healthcare outcomes. With a track record of success, we empower innovators, generic manufacturers, and consumer health companies to navigate the complex drug development landscape and achieve commercial success.
At Maqtox, we deliver a comprehensive suite of Chemistry, Manufacturing, and Controls (CMC) services.
At Maqtox, we understand that navigating the complex regulatory landscape for agrochemical registration requires expertise and precision
At Maqtox, we offer comprehensive in vitro and in vivo studies to support agrochemical compound registration.
At Maqtox, our laboratory testing services are designed to provide comprehensive and precise support for your research and development.
At Maqtox, we provide a comprehensive range of drug development services designed to advance your lead candidates
At Maqtox, we provide transformative, customer-centric drug discovery solutions designed to accelerate innovation and deliver results.
"Thanks to Maqtox, we were able to navigate complex global regulatory requirements seamlessly. Their strategic guidance and detailed dossier preparation were crucial for our product’s approval."
"Maqtox’s drug discovery services are unmatched. Their ability to deliver high-quality results on time has been instrumental in advancing our pipeline to clinical trials."
"The team at Maqtox exceeded our expectations with their deep scientific expertise and personalized approach. Their comprehensive laboratory testing services have been a cornerstone of our product."
"Maqtox has been an exceptional partner in navigating the regulatory landscape for our new product. Their attention to detail and responsiveness made a complex process remarkably smooth."
MAQTOX, in collaboration with Telomir Pharmaceuticals, has made significant strides in the fight against age-related diseases through their groundbreaking research on Telomir-1. This novel therapeutic compound has shown promising results in the extension of telomeres
Read MoreIn a significant development within the field of aging research, MAQTOX has partnered with Telomir Pharmaceuticals to tackle one of the most common and debilitating conditions associated with aging chronic inflammation. This collaboration is around their promising lead.
Read MoreMAQTOX, a leader in drug discovery and development, recently presented a groundbreaking update on one of its most promising anti-aging compounds at the 2024 National University Health System (NUHS) Singapore.
Read MoreMAQTOX, a global leader in drug discovery and development, in partnership with Telomir Pharmaceuticals, showcased groundbreaking pre-clinical data on Telomir-1 at the NUHS Centre for Healthy Longevity Conference 2024 in Singapore.
Read More